JP2022549373A5 - - Google Patents
Info
- Publication number
- JP2022549373A5 JP2022549373A5 JP2022519782A JP2022519782A JP2022549373A5 JP 2022549373 A5 JP2022549373 A5 JP 2022549373A5 JP 2022519782 A JP2022519782 A JP 2022519782A JP 2022519782 A JP2022519782 A JP 2022519782A JP 2022549373 A5 JP2022549373 A5 JP 2022549373A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962907389P | 2019-09-27 | 2019-09-27 | |
| US62/907,389 | 2019-09-27 | ||
| PCT/US2020/052912 WO2021062298A1 (en) | 2019-09-27 | 2020-09-25 | Biomarker panel targeted to diseases due to multifactorial ontology of glycocalyx disruption |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022549373A JP2022549373A (ja) | 2022-11-24 |
| JPWO2021062298A5 JPWO2021062298A5 (https=) | 2023-10-11 |
| JP2022549373A5 true JP2022549373A5 (https=) | 2023-10-11 |
| JP7689518B2 JP7689518B2 (ja) | 2025-06-06 |
Family
ID=75166872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519782A Active JP7689518B2 (ja) | 2019-09-27 | 2020-09-25 | グリコカリックス破壊の多因子オントロジーによる疾患をターゲティングしたバイオマーカーパネル |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220390454A1 (https=) |
| EP (1) | EP4034164A4 (https=) |
| JP (1) | JP7689518B2 (https=) |
| AU (1) | AU2020356626A1 (https=) |
| CA (1) | CA3155843A1 (https=) |
| IL (1) | IL291667A (https=) |
| WO (1) | WO2021062298A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016123163A2 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| US12105099B2 (en) | 2021-04-28 | 2024-10-01 | Diotex Diagnostics, Llc | Methods and devices for quantitatively estimating syndecan-1 |
| CN115389773A (zh) * | 2022-09-22 | 2022-11-25 | 无锡市第二人民医院 | 糖萼脱落标志物在诊断和防治初发的2型糖尿病肾病早期肾损伤的应用 |
| WO2025049608A1 (en) * | 2023-08-28 | 2025-03-06 | Calroyhealth Sciences, Llc | Compositions and methods to protect and enhance structural and functional integrity of the intestinal glycocalyx |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2437491T3 (es) * | 2003-10-10 | 2014-01-10 | Alchemia Oncology Pty Limited | Modulación de la síntesis y degradación de hialuronano en el tratamiento de enfermedad |
| CA2511269A1 (en) * | 2004-07-07 | 2006-01-07 | F. Hoffmann-La Roche Ag | Multimarker panel based on p1gf for diabetes type 1 and 2 |
| EP2302395B1 (en) * | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| WO2008080030A2 (en) * | 2006-12-22 | 2008-07-03 | Abbott Laboratories | Cardiovascular autoimmune disease panel and methods of using same |
| WO2011115783A1 (en) * | 2010-03-15 | 2011-09-22 | Oregon Health & Science University | Methods for assessing the risk of cardiovascular disease |
| WO2012106152A1 (en) * | 2011-02-03 | 2012-08-09 | Abbott Laboratories | Methods of prognosis and diagnosis in chronic heart failure |
| US9086412B2 (en) * | 2012-12-31 | 2015-07-21 | University Of Louisville Research Foundation, Inc. | Extracellular vesicle-associated protein markers of cancer |
| EP2965088B1 (en) * | 2013-03-04 | 2018-12-05 | IQ Products B.V. | Prognostic marker to determine the risk for early-onset preeclampsia |
| WO2016123163A2 (en) * | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| WO2016126662A1 (en) * | 2015-02-03 | 2016-08-11 | Kardiatonos, Inc. | Compounds for the prevention and treatment of vascular disease |
| WO2016164534A1 (en) * | 2015-04-09 | 2016-10-13 | Kardiatonos, Inc. | Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage |
| WO2016176089A1 (en) * | 2015-04-29 | 2016-11-03 | Kardiatonos, Inc. | Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage |
| WO2017136652A1 (en) * | 2016-02-04 | 2017-08-10 | Tarveda Therapeutics, Inc. | Stapled peptide conjugates and particles |
| JP7420557B2 (ja) * | 2017-03-07 | 2024-01-23 | オルト－クリニカル ダイアグノスティックス インコーポレイテッド | 分析物を検出するための方法 |
-
2020
- 2020-09-25 CA CA3155843A patent/CA3155843A1/en active Pending
- 2020-09-25 JP JP2022519782A patent/JP7689518B2/ja active Active
- 2020-09-25 EP EP20868963.8A patent/EP4034164A4/en active Pending
- 2020-09-25 US US17/762,703 patent/US20220390454A1/en active Pending
- 2020-09-25 WO PCT/US2020/052912 patent/WO2021062298A1/en not_active Ceased
- 2020-09-25 AU AU2020356626A patent/AU2020356626A1/en not_active Abandoned
-
2022
- 2022-03-24 IL IL291667A patent/IL291667A/en unknown